Progressive Retinal Atrophy (PRA) is a well-known inherited condition affecting the eyes of dogs, leading to gradual blindness without causing pain but affecting quality of life. While it cannot be prevented, cured or reversed, careful management through genetic testing can help control its spread within susceptible breeds.
This condition is passed genetically from parent to puppies and not contagious between dogs. PRA affects the retina's photoreceptor cells—the rods and cones responsible for vision clarity and colour perception.
There are many variants of PRA, each linked to different gene mutations. Hence, specific tests target individual PRA variants. In particular, Rod-Cone Dysplasia Type 1 (PRA-RCD1) is an early-onset form predominantly found in the Irish setter breed, often manifesting signs well before the dog is one year old.
PRA-RCD1 affects both cones and rods in the retina, starting to damage photoreceptors from around 10 days old—just as the puppies begin to open their eyes. This early onset leads to symptoms like night blindness emerging from approximately one month of age and usually progresses to complete blindness by around one year.
This form of PRA is caused by a recessive nonsense mutation in the PDE6B gene, which leads to a dysfunctional enzyme essential for normal photoreceptor function. The degeneration follows an autosomal recessive inheritance pattern, meaning dogs need two copies of the faulty gene to be affected.
The RCD1 variant primarily affects the Irish setter breed, so dogs of this lineage or crossbreeds with Irish setter ancestry are at risk. Early genetic screening and responsible breeding decisions are vital to reduce the incidence of PRA-RCD1.
Progressive Retinal Atrophy RCD1 inherits in an autosomal recessive manner with these possible parental gene combinations:
Understanding these genetic probabilities is crucial for breeders planning matings to prevent affected puppies.
To identify if your dog carries the PRA-RCD1 mutation, arrange a genetic test through your veterinary practice. The process involves taking a cheek swab or other DNA sample from your dog, which is sent to an approved laboratory in the UK for analysis.
You can consult The Kennel Club’s list for accredited laboratories performing PRA-RCD1 testing.
Test results indicate if the dog is clear, a carrier, or affected, guiding responsible breeding decisions to avoid passing the disease on.
There is currently no treatment or cure for PRA-RCD1, so genetic testing is the key method to control its occurrence. Responsible breeders use these test results to avoid mating two carriers or affected dogs, thus reducing PRA prevalence in the Irish setter gene pool.
For dog owners, knowing the PRA status of their pet allows for early understanding of potential vision issues and preparedness for changes in their dog's needs.
Quick Answer: Progressive retinal atrophy (PRA) is a group of inherited eye diseases causing progressive loss of vision and eventual blindness in dogs.
PRA involves degeneration of the retina's light-sensitive cells. Different forms affect various dog breeds, with symptoms ranging from night blindness to total vision loss, typically worsening over time.
Quick Answer: Prevent PRA by performing DNA testing on breeding dogs to identify carriers and affected individuals, then breeding only clear dogs or pairing carriers responsibly.
Breeders must rely on genetic screening for specific PRA variants like RCD1 to avoid producing affected puppies. Using reputable breeders and genetic health screenings are best practices.
When looking for Irish setter puppies, choosing reputable Irish setter breeders who test for PRA and other health conditions is imperative. This ensures healthier puppies with reduced risk of inherited diseases.
Check breeder credentials, health screening practices, and seek recommendations from breed clubs or The Kennel Club.